Abstract:The number of older individuals receiving a kidney transplant as replacement therapy has significantly increased in the past decades and this increase is expected to continue. Older patients have a lower rate of acute rejection but an increased incidence of death with a functioning graft. Several factors, including an increased incidence of infections, post-transplant malignancy and cardiovascular comorbidity and mortality, contribute to this increased risk. Notwithstanding, kidney transplantation is still the best form of kidney replacement therapy in all patients with chronic kidney disease, including in older individuals. The best form of immunosuppression and the optimal dose of these medications in older recipients remains a topic of discussion. Pharmacological studies have usually excluded older patients and when included, patients were highly selected and their numbers insignificant to draw a reasonable conclusion. The reduced incidence of acute rejection in older recipients has largely been attributed to immunosenescence. Immunosenescence refers to the aging of the innate and adaptive immunity, accumulating in phenotypic and functional changes. These changes influences the response of the immune system to new challenges. In older individuals, immunosenescence is associated with increased susceptibility to infectious pathogens, a decreased response after vaccinations, increased risk of malignancies and cardiovascular morbidity and mortality. Chronic kidney disease is associated with premature immunosenescent changes, and these are independent of aging. The immunosenescent state is associated with low-grade sterile inflammation termed inflammaging . This chronic low-grade inflammation triggers a compensatory immunosuppressive state to avoid further tissue damage, leaving older individuals with chronic kidney disease in an immune-impaired state before kidney transplantation. Immunosuppression after transplantation may further enhance progression of this immunosenescent state. This review covers the role of immunosenescence in older kidney transplant recipients and it details present knowledge of the changes in chronic kidney disease and after transplantation. The impact of immunosuppression on the progression and complications of an immunosenescent state are discussed, and the future direction of a possible clinical implementation of immunosenescence to individualize/reduce immunosuppression in older recipients is laid out.

Summary of ISN Forefronts Symposium 2015: ‘immunomodulation of Cardio-Renal Function’

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap

Summary of the International Conference on Onco-Nephrology: an Emerging Field in Medicine.

Immunology of Kidney Disease

Revealing Potential Diagnostic Gene Biomarkers Associated with Immune Infiltration in Patients with Renal Fibrosis Based on Machine Learning Analysis.

Pathophysiological Mechanisms in Cardiorenal Syndrome

Progress in the Application of Immunosuppressants to Renal Transplant

A new era in the science and care of kidney diseases

Immune–stromal interplay shapes kidney function in health and disease

Frontiers and future perspectives of neuroimmunology

Advancements in understanding the mechanisms of lung-kidney crosstalk

Management and Treatment of Glomerular Diseases (part 2): Conclusions from A Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

The Advances of Single-Cell RNA-Seq in Kidney Immunology

Title Page Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives

Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond

Impaired systemic proteostasis and peripheral immune cell dysfunction in kidney diseases

Neuroimmune cross-talk in heart failure

Impact of Immunosenescence in Older Kidney Transplant Recipients: Associated Clinical Outcomes and Possible Risk Stratification for Immunosuppression Reduction

Cardiorenal Syndrome and Inflammation: A Forgotten Frontier Resolved by Sorbents?

Immunosenescence, Gut Dysbiosis, and Chronic Kidney Disease: Interplay and Implications for Clinical Management

Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases